Rehabtronics Welcomes New VP of Sales for the US
To support growing sales in the United States, Rehabtronics is pleased to welcome Davie Mendelsohn to its team. A veteran medical device industry sales executive, Davie has more than 20…
ReGrasp Bionic Glove Now Available in the United States to Help Stroke Patients Regain Hand Mobility
VANCOUVER, BC, May 11, 2022 /PRNewswire/ — ReGrasp Bionic Glove, a medical device designed to help patients speed hand rehabilitation following a stroke or injury, is now available in the United States for patients to…
ReGrasp Bionic Glove Now Available in the US
ReGrasp uses FES technology to help stroke patients regain hand mobility and perform daily tasks ReGrasp Bionic Glove, a medical device designed to help patients speed hand rehabilitation following a…
Rehabtronics Receives $1.25 Million from Genome BC to Enable Free Quality Improvement Trials of Prelivia
Rehabtronics is pleased to announce that Genome BC is providing $1.25 million to support commercialization of Prelivia, the world’s first neuroscience-based technology designed to protect patients against deadly pressure injuries…
Rehabtronics Raises $1.6 Million in Oversubscribed Funding
Funds will be used to commercial Prelivia, technology designed to protect patients from pressure injuries Vancouver, BC, November 18, 2021 – Rehabtronics, a medical device company, has raised $1.6 million…
November 18 is Pressure Injury Prevention Day
Organizations across the world have been observing World Wide Pressure Injury Prevention Day on the third Thursday of the month since 2013. This year’s awareness programs will be held on…
Prelivia Receives FDA Clearance
The U.S. Food and Drug Administration has provided 510 (k) Clearance for Prelivia, a neurostimulation device that promotes healthy blood circulation and maintains healthy tissue in people who are bedridden or chair bound. Annually, more than 2.5 million people in the United States suffer from pressure injuries, also known as bed sores, and up to 60,000 people die.